An observational study evaluating treatment patterns and safety of safinamide in patients with Parkinson's disease in clinical practice

Trial Profile

An observational study evaluating treatment patterns and safety of safinamide in patients with Parkinson's disease in clinical practice

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2017

At a glance

  • Drugs Safinamide (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms The SYNAPSES study
  • Most Recent Events

    • 14 Jul 2017 New trial record
    • 27 Jun 2017 Results from the feasibility evaluation of SYNAPSES presented at the 3rd Congress of the European Academy of Neurology
    • 08 Jun 2017 Trial design presented at the 21st International Congress of Parkinson's Disease and Movement Disorders.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top